Patent panic gives green light to mega pharma deals Financial Times
Pressure drugmakers face over expiries means big takeovers can lack scrutiny.
Patent panic gives green light to mega pharma deals Financial Times
Pressure drugmakers face over expiries means big takeovers can lack scrutiny.